← Leaderboards
Jian-Ting Zhang
Indiana Univ-Purdue Univ At Indianapolis
$8,618,248
Attributed
$8,880,457
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $782.5K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,880,457 · 9
By mechanism
R01$8,494,032 · 8
R21$386,425 · 1
Top collaborators
- Jasmine Jingyuan Liu1 shared
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularMalignant NeoplasmsProteinsCancer CellPharmaceutical PreparationsChemotherapyCellsSuccessBiochemicalTherapeutic AgentsUniversitiesMediatingEnvironmentIndianaMembrane Transport ProteinsBinding (Molecular Function)LeadTherapeutic TargetInhibitor/AntagonistStructureDrug ResistanceResponseDimerDimerization
Grant awards (32)
Molecular basis and targeting of FASN in expanding PARPi utility for TNBC$524,419
R01 · FY2025 · CA · contact PI
Targeting FASN to eliminate metastatic breast cancer in the brain$205,853
R21 · FY2024 · CA · contact PI
Targeting FASN to eliminate metastatic breast cancer in the brain$180,572
R21 · FY2023 · CA · contact PI
Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathwayï¢$344,884
R01 · FY2022 · CA · contact PI
Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathwayï¢$351,923
R01 · FY2021 · CA · contact PI
Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathwayï¢$351,923
R01 · FY2020 · CA · contact PI
Molecular targeting the translational control axis in Wnt/beta-catenin signaling pathwayï¢$351,322
R01 · FY2018 · CA · contact PI
Molecular targeting the translational control axis in Wnt/β-catenin signaling pathway$7,381
R01 · FY2018 · CA · contact PI
Molecular targeting the translational control axis in Wnt/β-catenin signaling pathway$358,703
R01 · FY2017 · CA · contact PI
Therapeutic targeting of stratifin structure and function$300,665
R01 · FY2014 · CA · contact PI
Therapeutic targeting of stratifin structure and function$291,366
R01 · FY2013 · CA · contact PI
Therapeutic targeting of stratifin structure and function$309,964
R01 · FY2012 · CA · contact PI
Therapeutic targeting of stratifin structure and function$309,964
R01 · FY2011 · CA · contact PI
Targeting the amino terminal gate of human MRP1$279,215
R01 · FY2011 · CA · contact PI
Therapeutic targeting of stratifin structure and function$319,550
R01 · FY2010 · CA · contact PI
Targeting the amino terminal gate of human MRP1$287,850
R01 · FY2010 · CA · contact PI
Targeting the amino terminal gate of human MRP1$287,850
R01 · FY2009 · CA · contact PI
Targeting the oligomerization of human ABCG2$208,891
R01 · FY2009 · CA · contact PI
Targeting the amino terminal gate of human MRP1$287,850
R01 · FY2008 · CA · contact PI
Targeting the oligomerization of human ABCG2$208,891
R01 · FY2008 · CA · contact PI
Targeting the amino terminal gate of human MRP1$287,850
R01 · FY2007 · CA · contact PI
Role of p170 in lung tumorigenesis$285,759
R01 · FY2007 · CA · contact PI
Targeting the oligomerization of human ABCG2$208,891
R01 · FY2007 · CA · contact PI
Role of p170 in lung tumorigenesis$294,294
R01 · FY2006 · CA · contact PI
Targeting the oligomerization of human ABCG2$215,130
R01 · FY2006 · CA · contact PI
Role of p170 in lung tumorigenesis$301,376
R01 · FY2005 · CA
Role of p170 in lung tumorigenesis$301,376
R01 · FY2004 · CA
Role of p170 in lung tumorigenesis$298,680
R01 · FY2003 · CA
MOLECULAR BASES OF MULTIDRUG RESISTANCE IN CANCERS$243,633
R01 · FY2001 · CA
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN$222,138
R01 · FY2001 · GM
MOLECULAR BASES OF MULTIDRUG RESISTANCE IN CANCERS$236,538
R01 · FY2000 · CA
MECHANISM OF DRUG BINDING TO P-GLYCOPROTEIN$215,756
R01 · FY2000 · GM